Strategic Advisors LLC Purchases 2,208 Shares of Axon Enterprise, Inc $AXON

Strategic Advisors LLC lifted its position in Axon Enterprise, Inc (NASDAQ:AXON) by 99.0% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,439 shares of the biotechnology company’s stock after acquiring an additional 2,208 shares during the period. Strategic Advisors LLC’s holdings in Axon Enterprise were worth $3,186,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. AE Wealth Management LLC lifted its position in Axon Enterprise by 8.6% during the third quarter. AE Wealth Management LLC now owns 1,486 shares of the biotechnology company’s stock valued at $1,066,000 after buying an additional 118 shares during the period. Annis Gardner Whiting Capital Advisors LLC increased its stake in shares of Axon Enterprise by 14,650.0% in the 3rd quarter. Annis Gardner Whiting Capital Advisors LLC now owns 2,655 shares of the biotechnology company’s stock worth $1,905,000 after acquiring an additional 2,637 shares in the last quarter. New York State Common Retirement Fund lifted its position in Axon Enterprise by 2.1% during the 3rd quarter. New York State Common Retirement Fund now owns 38,639 shares of the biotechnology company’s stock valued at $27,729,000 after acquiring an additional 800 shares during the period. AustralianSuper Pty Ltd boosted its stake in Axon Enterprise by 2.2% during the third quarter. AustralianSuper Pty Ltd now owns 82,779 shares of the biotechnology company’s stock worth $59,406,000 after acquiring an additional 1,806 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. grew its holdings in Axon Enterprise by 11.5% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 34,381 shares of the biotechnology company’s stock worth $24,673,000 after purchasing an additional 3,555 shares during the period. 79.08% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts recently weighed in on AXON shares. UBS Group cut their price target on Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 5th. Weiss Ratings restated a “hold (c-)” rating on shares of Axon Enterprise in a research note on Monday, December 29th. Wall Street Zen downgraded shares of Axon Enterprise from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. The Goldman Sachs Group cut their price target on shares of Axon Enterprise from $940.00 to $800.00 and set a “buy” rating on the stock in a report on Wednesday, November 5th. Finally, Barclays decreased their price objective on shares of Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating for the company in a report on Thursday, November 6th. Fourteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $805.71.

Axon Enterprise Trading Down 9.9%

Shares of AXON stock opened at $549.86 on Thursday. The company has a current ratio of 3.12, a quick ratio of 2.89 and a debt-to-equity ratio of 0.57. Axon Enterprise, Inc has a 12-month low of $469.24 and a 12-month high of $885.91. The stock has a market capitalization of $43.39 billion, a P/E ratio of 174.01, a P/E/G ratio of 19.21 and a beta of 1.41. The firm’s 50 day moving average is $579.31 and its 200 day moving average is $672.62.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.46). Axon Enterprise had a net margin of 10.05% and a return on equity of 4.29%. The firm had revenue of $710.64 million for the quarter, compared to the consensus estimate of $704.83 million. During the same period in the previous year, the company earned $1.45 earnings per share. Axon Enterprise’s quarterly revenue was up 30.6% compared to the same quarter last year. Research analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Insider Activity

In related news, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, January 7th. The shares were sold at an average price of $619.01, for a total value of $6,190,100.00. Following the transaction, the chief executive officer owned 3,100,997 shares of the company’s stock, valued at approximately $1,919,548,152.97. This trade represents a 0.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction that occurred on Monday, December 8th. The shares were sold at an average price of $552.60, for a total transaction of $11,052,000.00. Following the sale, the president directly owned 249,502 shares of the company’s stock, valued at approximately $137,874,805.20. This represents a 7.42% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 60,540 shares of company stock worth $34,684,738. Company insiders own 5.70% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.